If your insurance doesn’t cover Zepbound, you can still choose to purchase the medication as prescribed and use the savings program. This could reduce the cost to $550 for a 1-month supply ...

There are ways you can travel with Zepbound to ensure it remains safe and effective to use. Zepbound (tirzepatide) is a prescription injection that comes as a single-dose pen or single-dose vial.

In fact, the FDA does not recommend using compounded GLP-1 drugs due to safety concerns. Ro is a telehealth company. To get Zepbound from Ro, you must join the company’s Body Program.

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...

There’s no direct link between vision loss and taking the weight loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...

During the quarter, Lilly said it won approval in the U.S. for the use of Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity. Sales of the drug jumped to $1.9 ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations. Zepbound sales reached $1.9 billion in ...

More than 69.2 million FDA-approved weight-loss prescriptions were dispensed in the U.S. from July 2017 through February 2024.

During the quarter, Lilly said it won approval in the U.S. for the use of Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity. It also won approval of Omvoh in the U.S ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight.

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion. The drugmaker ...